Overview:
Regulatory intelligence focuses on understanding regulations as well as less obvious expectations in order to achieve regulatory success. This can be with new product submissions as well as legacy product lifecycle management. Knowledge gained from regulatory intelligence allows life sciences companies to get products to market faster, maintain regulatory compliance, and better serve patients.
Why you should Attend:
Regulatory is in the critical path to product launch, which means speed and quality of the submissions process is essential to getting products to market (and to patients) as quickly as possible. However, regulatory pathways and processes are complex and not fully detailed in published regulations.
Insights gained from a knowledge management approach to regulatory intelligence is essential to achieve right-first-time performance. The webinar will present multiple approaches to capturing insights to health authority expectations. These approaches include mining health authority correspondence, leveraging regulatory systems analytics, identifying experts inside and outside of the organization, and, where possible, frequent engagement with the authority.
Areas Covered in the Session:
Who Will Benefit:
Patterson Shafer has over 30 years of experience solving complex global challenges and helping clients achieve their strategic and operational objectives in the areas of quality and compliance, regulatory affairs and operations, clinical, safety and surveillance, manufacturing, supply chain, medical affairs and commercial.
Pat has extensive knowledge and experience with post-market surveillance and field actions, including recall readiness. His work in that area includes identifying technology solutions to detect quality and safety signals, reengineered pharmacovigilance, complaint, CAPA and field action (recall) processes, and redesigned medical review organizations to advance compliance, safety, and operational efficiency. He has written recall best practices playbooks, published articles, and presented at multiple conferences on the subject, in addition to overseeing multiple recalls for medical device companies.